Skip to main content
Premium Trial:

Request an Annual Quote

Ventana Extends CDx Deal with Bayer

NEW YORK (GenomeWeb News) – Roche's Ventana Medical Systems today announced an extension of an agreement to develop companion diagnostics for Bayer Pharma's targeted therapy projects.

The firms inked an agreement in early 2012 to develop a molecular companion diagnostic for a Bayer antibody-drug conjugate, and today's deal is for the development of diagnostic tests for Bayer's biomarker-targeted therapeutics, Ventana said. The collaboration will make use of Ventana's immunohistochemistry technologies.

As part of the agreement, Ventana will create a team of experts with resources focused exclusively on Bayer projects. Financial and other terms were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.